Sherin Al-Safadi
Chief Tech/Sci/R&D Officer at RADIOPHARM THERANOSTICS LIMITED
Profile
Sherin Al-Safadi is currently the Vice President-Medical & Corporate Affairs at Radiopharm Theranostics Ltd.
She previously worked as the Director-Global Medical Affairs Oncology Strategy at Bayer Pharmaceuticals Corp.
and as the Vice President-Medical Affairs at POINT Biopharma Global, Inc. She holds a graduate degree from McGill University, a doctorate from Concordia University, and an MBA from John Molson School of Business.
Sherin Al-Safadi active positions
| Companies | Position | Start |
|---|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Chief Tech/Sci/R&D Officer | 2023-07-23 |
Former positions of Sherin Al-Safadi
| Companies | Position | End |
|---|---|---|
| Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | - |
| POIT BIOP | Chief Tech/Sci/R&D Officer | - |
Training of Sherin Al-Safadi
| Concordia University | Doctorate Degree |
| McGill University | Graduate Degree |
| John Molson School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| POIT BIOP | Health Technology |
| RADIOPHARM THERANOSTICS LIMITED | Health Services |
| Private companies | 1 |
|---|---|
| Bayer Pharmaceuticals Corp. |
- Stock Market
- Insiders
- Sherin Al-Safadi
